Clinical Oncology Society of Australia


COSA Annual Scientific Meeting (ASM)

The 2017 COSA ASM will be held at the new International Convention Centre Sydney. We have changed our schedule slightly and will run from Monday 13 to Wednesday 15 November, with pre-conference workshops on Sunday 12 November. The program for COSA’s 44th ASM will focus on immunotherapy, with a subtheme of implementing quality and safety in cancer care.

Invited international speakers confirmed to date:

  • Dr Matthew Hellmann – medical oncologist from Memorial Sloan Kettering (MSK) in the US. Dr Hellmann specialises in the care of patients with lung cancers. He is a member of MSK’s Immunotherapeutics Group, where they design and lead early-phase clinical trials of immunotherapies for patients with a variety of cancers.
  • Dr Monika Krzyzanowska – medical oncologist and health services researcher at the Princess Margaret Cancer Centre in Toronto, Canada. Dr Krzyzanowska’s research focuses on the science and practice of healthcare quality as it relates to the delivery of cancer care. She is the Chair Elect of the ASCO Quality Care Symposium.
  • Dr Anja Mehnert – psychologist at the University Medical Centre Leipzig in Germany. Dr Mehnert’s main research focus includes the prevalence of mental disorders in cancer patients and the impact of cancer and treatment-related factors. She also has extensive expertise in investigating issues of employment and work in cancer survivorship, as well as distress and demoralisation in patients with advanced disease and palliative care.
  • Dr Dana Rollison – Vice President and Chief Data Officer at Moffitt Cancer Centre in Florida, US. Her work bridges analytics strategies across research, clinical and operations. Dr Rollison’s primary research focuses on the potential role of viral infections in cancer etiology and the epidemiology of myelodysplastic syndromes.
  • Prof Mary Wells – Professor of Cancer Nursing Research and Practice at the Nursing, Midwifery and Allied Health Professions Research Unit, University of Stirling, Scotland UK.  Professor Wells is a cancer nurse with a clinical academic background in health services research within oncology.

These international experts will be joined by an esteemed Australian faculty, including Jonathan Cebon, Jon Emery, Georgina Long, Alex Menzies, Richard Scolyer, Mark Shackleton, Shankar Siva, and Christopher Steer to name a few. Full details of speakers, the program, abstract submission and registration information is available on the conference website www.cosa2017.org.

Working with Cancer Council Australia

In COSA’s role as medical and scientific advisors to Cancer Council Australia, we often collaborate on submissions to government and have submitted the following joint submissions:

  • National Digital Health Strategy Consultation (January 2017)NSW Health Consultation on Statewide Biobanking Consent (February 2017)
  • Response to the National Health Genomics Policy Framework 2017-2020 (March 2017)
  • Senate inquiry into funding for research into cancers with low survival rates (March 2017)
  • Provisional approval pathway for prescription medicines: Proposed process and post-market requirements (May 2017).

For more information about COSA activities please visit www.cosa.org.au

Marie Malica
Executive Officer, COSA

Be the first to know when a new issue is online. Subscribe today.